- Home
- SAFE vs CERT Comparison
SAFE vs CERT Comparison
Compare SAFE & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SAFE | CERT |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SAFE | CERT |
|---|---|---|
| Price | $13.43 | $9.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $19.56 | $14.50 |
| AVG Volume (30 Days) | 453.7K | ★ 2.8M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 5.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.57 | 0.07 |
| Revenue | $398,968,000.00 | ★ $415,551,000.00 |
| Revenue This Year | $0.84 | $10.82 |
| Revenue Next Year | $3.56 | $6.77 |
| P/E Ratio | ★ $8.57 | $136.31 |
| Revenue Growth | 2.96 | ★ 11.47 |
| 52 Week Low | $12.76 | $8.03 |
| 52 Week High | $21.90 | $15.69 |
Technical Indicators
Market Signals| Indicator | SAFE | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 44.77 | 44.31 |
| Support Level | $13.29 | $8.75 |
| Resistance Level | $13.75 | $9.72 |
| Average True Range (ATR) | 0.41 | 0.37 |
| MACD | 0.08 | 0.21 |
| Stochastic Oscillator | 46.23 | 67.85 |
Price Performance
Historical ComparisonAbout SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.